Judge Nixes Glaxo's Bid To Strike Paxil Testimony

Law360, New York (September 17, 2007, 12:00 AM EDT) -- A federal judge has granted in part and denied in part GlaxoSmithKline's bid to strike portions of the plaintiffs' expert witness discovery testimony in a case alleging that the antidepressant Paxil caused a teenager's violent behavior and suicide attempt.

In an order handed down Monday in the U.S. District Court for the Northern District of California, Judge Martin J. Jenkins granted a request by defendant SmithKline Beecham Corp., which does business as GlaxoSmithKline, for leave to resume Dr. Joseph Glenmullen’s deposition for an additional three-and-a-half hours....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.